Ifosfamide-based chemotherapy for previously treated lung cancer patients

Chinese Medical Journal (Taipei)

Volumn 61, Issue 7, 1998, Pages 389-396

  Chen, Yuh Min ^a,b   Liu, Jacqueline Ming ^c   Wu, Ming Fang ^a,b   Wu, Hsiao Wei ^c   Lin, Wei Chun ^c   Tsai, Chun Ming ^a,b   Perng, Reury Perng ^a,b   Whang Peng, Jacqueline ^c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Chemotherapy; Ifosfamide; Lung cancer

Indexed keywords

EPIRUBICIN; FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG RESISTANCE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MALE; NEUTROPENIA; TREATMENT OUTCOME;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SMALL CELL; EPIRUBICIN; FEMALE; FLUOROURACIL; HUMANS; IFOSFAMIDE; LEUCOVORIN; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; SALVAGE THERAPY;

EID: 0031904740     PISSN: 05781337     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Chen YM. New chemotherapeutic agents for non-small cell lung cancer. Clin Med (ROC) 1996;37:22-5.
2. Rapp E, Pater JL, Willan A, Cormier Y, Murray N, Evans WK, et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: report of a Canadian multicenter randomized trial. J Clin Oncol 1988;6:633-41.
3. Bunn PA Jr. The expanding role of cisplatin in the treatment of non-small-cell lung cancer. Semin Oncol 1989;16(suppl 6):10-21.
4. Souquet PJ, Chauvin F, Boissel JP, Cellerino R, Cormier Y, Ganz PA, et al. Polychemotherapy in advanced non-small-cell lung cancer: a meta-analysis. Lancet 1993;342: 19-21.
5. Chevalier TL. Chemotherapy for advanced NSCLC: will meta-analysis provide the answer? Chest 1996;109: 107S-9S.
6. Chen YM, Yang S, Perng RP, Tsai CM. Superior vena cava syndrome revisited. Jpn J Clin Oncol 1995;25:32-6.
7. Seifter EJ, Ihde DC. Therapy of small cell lung cancer: a perspective on two decades of clinical research. Semin Oncol 1988;15:278-99.
8. Viallet J, Ihde DC. Systemic therapy for small-cell lung cancer: old themes replayed, new ones awaited. J Clin Oncol 1989;7:985-7.
9. Johnson BE. Management of small-cell lung cancer. Clin Chest Med 1993;14:173-87.
10. Colvin M. The comparative pharmacology of cyclophosphamide. Semin Oncol 1982;9(suppl 1):2-7.
11. Sarosy G. Ifosfamide - pharmacologic overview. Semin Oncol 1989;16(suppl 3):2-8.
12. Dechant KL, Brogden RN, Pilkington T, Faulds D. Ifosfamide/mesna: a review of its antineoplastic activity, pharmacokinetic properties and therapeutic efficacy in cancer. Drugs 1991;42:428-67.
13. Thatcher N, Lind M, Campos ED, Cerny T. Novel approaches with ifosfamide in small cell lung cancer. Semin Oncol 1992;19(suppl 1):68-77.
14. Ihde DC. Chemotherapy for non-small cell lung cancer. In: Education Book of American Society of Clinical Oncology. Alexandria, VA: American Society of Clinical Oncology, 1995:128-31.
15. Bramwell VH, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, et al. Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer Clin Oncol 1987;23:311-21.
16. Mountain CF. A new international staging system for lung cancer. Chest 1986;89(suppl):225-323.
17. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-55.
18. World Health Organization. WHO Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication No. 48. Geneva: World Health Organization, 1979.
19. Ettinger DS. The place of ifosfamide in chemotherapy of small cell lung cancer: the Eastern Cooperative Oncology Group experience and a selected literature update. Semin Oncol 1995;22(suppl 2):23-7.
20. Loehrer PJ, Ansari R, Gonin R, Monaco F, Fisher W, Sandler A, et al. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier oncology group study. J Clin Oncol 1995;13:2594-9.
21. Graziano SL, Herndon JE, Richards F, Difino S, Modeas C, Duggan DB, et al. A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer. A cancer and leukemia group B study. Cancer 1993;72:62-8.
22. Chen YM, Wu MF, Perng RP, Chou CM, Yang KY, Lin WC, et al. Phase II study of ifosfamide and etoposide chemotherapy for extensive-disease small cell lung cancer. Jpn J Clin Oncol 1997;27:76-9.
23. Faylona EA, Loehrer PJ, Ansari R, Sandier AB, Gonin R, Einhorn LH. Phase II study of daily oral etoposide plus ifosfamide plus cisplatin for previously treated recurrent small-cell lung cancer: a Hoosier oncology group trial. J Clin Oncol 1995;13:1209-14.
24. Einhorn LH, Loehrer PJ. Hoosier oncology group studies in extensive and recurrent small cell lung cancer. Semin Oncol 1995;22:28-31.
25. Klastersky J, Sculier JP, Ravez P, Libert P, Michel J, Vandermoten G, et al. A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 1986;4:1780-6.
26. Klastersky J, Sculier JP, Bureau G, Libert P, Ravez P, Vandermoten G, et al. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 1989;7:1087-92.
27. Klastersky J, Sculier JP, Lacroix H, Dabouis G, Bureau G, Libert P, et al. A randomized study comparing cisplatin or carboplatin with etoposide in patients with advanced non-small-cell lung cancer: European Organization for Research and Treatment of Cancer Protocol 07861. J Clin Oncol 1990;8:1556-62.
28. Perng RP, Chen YM, Liu JM, Tsai CM, Lin WC, Yang KY, et al. Gemcitabine versus the combination of cisplatin and etoposide in patients with inoperable non-small cell lung cancer in a phase II randomized study. J Clin Oncol 1997;15:2097-102.
29. Miller VA, Rigas JR, Pisters KM, Pfister DG, Heelan RT, Kris MG. Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy. Am J Clin Oncol 1995;18:303-6.